The chemical class designated as ANKRD28 Inhibitors encompasses a range of compounds characterized by their ability to modulate the function of the ANKRD28 protein. This modulation is achieved through indirect mechanisms, given the absence of direct inhibitors for ANKRD28. ANKRD28, featuring ankyrin repeats, is implicated in various cellular processes, primarily through protein-protein interactions. The inhibitors in this class target the broader cellular pathways and mechanisms in which ANKRD28 is involved. They operate on the principle of influencing the cellular context or the signaling pathways that dictate ANKRD28's functional role within the cell. This approach is necessitated by the nature of ANKRD28, which, like many proteins involved in complex protein interactions, does not lend itself easily to direct inhibition due to the lack of a traditional active site or a well-defined ligand-binding domain.
The inhibitors typically target key cellular pathways such as signal transduction, gene expression regulation, and protein degradation. By modulating these pathways, these compounds can influence the activity of ANKRD28. For instance, compounds that alter signal transduction can change the signaling environment in which ANKRD28 operates, thereby modulating its role in these pathways. Similarly, compounds that affect gene expression can indirectly influence ANKRD28's involvement in chromatin remodeling or transcriptional regulation. Additionally, inhibitors that impact protein degradation pathways can alter the stability and turnover of ANKRD28, thereby affecting its cellular concentration and functionality. The diversity of these compounds reflects the multifaceted nature of ANKRD28 and underscores the complex interplay between different cellular components and signaling networks. The approach to modulating ANKRD28's function thus requires an understanding of the broader cellular context and the intricate network of interactions in which this protein participates. The ability of these inhibitors to modulate ANKRD28's function highlights not just the complexity of targeting such a protein, but also the nuanced understanding required to manipulate its activity within the dense web of cellular interactions and processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could possibly inhibit ANKRD28 by altering gene expression, potentially affecting its role in gene regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Could possibly inhibit ANKRD28 by influencing signal transduction pathways, thereby affecting its function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Could possibly inhibit ANKRD28 by affecting cytoskeletal organization and cellular transport, where ANKRD28 might be involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Could possibly inhibit ANKRD28 by modifying stress response pathways, influencing its function in these processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could possibly inhibit ANKRD28 by affecting cellular processes in the MAPK/ERK pathway where it is implicated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Could possibly inhibit ANKRD28 by affecting signaling pathways and intracellular transport mechanisms. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Could possibly inhibit ANKRD28 by affecting protein degradation pathways, impacting its function or stability. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Could possibly inhibit ANKRD28 by intersecting with cellular stress responses in the MAPK signaling pathway. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Could possibly inhibit ANKRD28 by affecting cell cycle regulation, influencing processes where it is involved. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Could possibly inhibit ANKRD28 by affecting intracellular transport and cytoskeletal organization. | ||||||